IMNNImunonSigning up patients
Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Ovarian Cancer · Fallopian Tube Cancer · Primary Peritoneal Cancer
0Calmworry score, out of 100
No strong warning signs right now. The score counts warning signs; it is not a prediction.
Why this score
No warning signs right now. That's why the score is 0.
Score over time
- Stage
- Phase 1/2
- Patients
- 30 (planned)
- Started
- Feb 10, 2023
- Main results expected
- Jun 30, 2027
- Fully finished
- Aug 30, 2028
- Results posted
- not yet
What counts as success
The trial's main goal(s), called the “primary outcome.”
Minimal Residual Disease
Measured over: 8 months
Changes Tremor has spotted
No changes since Tremor started watching this trial.
Show details (technical version)
Score inputs
- none
Raw record changes
- none yet
Trial ID NCT05739981 · record last updated 2026-10-05 · checked 2026-11-09 15:47 UTC